Clinical Trials Logo
  1. Home
  2. Laparoscopic Hepatectomy
  3. NCT01471080

A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver

Liver Clinical Trial

Official title:
A Prospective Controlled Study on Treatment of Giant Cavernous Hemangiomas of the Liver：RFA Versus Laparoscopic Hepatectomy.

Clinical Trial Summary

In the past, the investigators often treated giant cavernous hemangiomas of the liver by hepatectomy.Recently RFA and laparoscopic hepatectomy are also available and could be applied to cure this disease.But we can't get a clear answer about their effectiveness and safety. Hence the investigators conduct this study to explore the effectiveness and efficiency of the these two methods and compare their short to mid-term outcomes.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01471080
Study type Interventional
Source Southwest Hospital, China
Contact
Status Completed
Phase N/A
Start date November 2011
Completion date January 2014
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01201096 - Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE) N/A
Terminated NCT01163526 - Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies N/A
Completed NCT00250796 - Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma Phase 2
Not yet recruiting NCT05389241 - Laparoscopic Augmented Reality for Identification of Liver Lesions - a Pre-clinical Randomized Cross-over Trial N/A
Recruiting NCT05879159 - Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection N/A
Completed NCT00924248 - Primovist Regulatory Post Marketing Surveillance (PMS) N/A
Completed NCT01420211 - Influence of the OATP1B1 and OATP1B3 Genotype on the Hepatic Uptake of Primovist® Phase 1/Phase 2
Completed NCT00494312 - Safety Study of Pioglitazone Compared To Glyburide on Liver Function Phase 4
Withdrawn NCT00718055 - Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients Phase 4
Terminated NCT00708877 - Liver Transplantation for Cholangiocarcinoma N/A
Enrolling by invitation NCT06364865 - AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study
Recruiting NCT00343122 - Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus Polygeline Phase 4
Active, not recruiting NCT04721782 - Effects of Maternal Smoking on Fetal Liver Circulation
Recruiting NCT03881306 - DEBOXA for Inoperable NET Liver Metastases Phase 1/Phase 2
Recruiting NCT01143935 - Estimation of Standard Liver Volume in the Indian Population N/A
Completed NCT00422838 - Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. N/A
Completed NCT03876574 - Hepatic Artery Infusion Pump for NPC Liver Metastases Phase 1
Recruiting NCT06195943 - Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis N/A
Completed NCT03735706 - Relationship Between Contrast Media Volume and Tube Voltage in CT for Optimal Liver Enhancement, Based on Body Weight. N/A
Not yet recruiting NCT06153914 - SALT for Patients With Hepatic Cirrhosis N/A